Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealiusPHCRF 47 Median PS Value is $4.17 as of Jul. 15, 2026, which is 421% above its 10-year median of 0.80. GuruFocus rates PHCRF with a GF Score™ of 47/100 and a GF Value™ of $2.23. The stock has 7 warning signs investors should review. Among 89 Medical Diagnostics & Research companies, Healius ranks better than 92.13% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Healius's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $1.231. Healius's 10-Year median PS Ratio is 3.3875. Therefore, the Median PS Value for today is $4.17.
As of today (2026-07-15), Healius's share price is $0.84. Healius's Median PS Value is $4.17. Therefore, Healius's Price to Median PS Value for today is 0.20.
The historical rank and industry rank for Healius's Median PS Value or its related term are showing as below:
PHCRF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.2 Med: 0.8 Max: 1.24
Current: 0.2
During the past 13 years, the highest Price to Median PS Value of Healius was 1.24. The lowest was 0.20. And the median was 0.80.
PHCRF's Price-to-Median-PS-Value is ranked better than 92.13% of 89
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.91
vs PHCRF: 0.20
Healius (OTCPK:PHCRF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Healius's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.84
/
4.17
=
0.20
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healius Median PS Value Related Terms
Healius Median PS Value Historical Data
* Premium members only.
The historical data trend for Healius's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PHCRF vs TMO, DHR, IDXX: Median PS Value Comparison
For the Diagnostics & Research subindustry, Healius's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Healius Price-to-Median-PS-Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Healius's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Healius's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 3.3875.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Healius's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $1.231.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Healius (PHCRF) has a Median PS Value of $4.17 as of Jul. 15, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Healius and its competitors. This is 421% above median its historical median of 0.80. Over the past decade, Healius' Median PS Value has ranged from 0.20 to 1.24. According to the industry distribution chart, Healius ranks #7 out of 89 companies in the Medical Diagnostics & Research industry, placing it in the top 7.9%.
Is Healius' Median PS Value too high?
Healius' current Median PS Value of $4.17 is 421% above median its 10-year median of 0.80. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 1.24. The Medical Diagnostics & Research industry median Median PS Value is 0.91. Healius' value of $4.17 is 358.2% above this industry median. Based on the distribution chart, Healius ranks #7 out of 89 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Healius has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Healius' Median PS Value compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Healius ranks #7 out of 89 companies for Median PS Value. This places Healius in the top 8% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.91. Healius' value of $4.17 is 358.2% above this benchmark. Historically, Healius' own Median PS Value has ranged from 0.20 to 1.24 over the past decade. While the company's 10-year median is 0.80 vs. the industry median of 0.91, Healius has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Diagnostics & Research company?
The median Median PS Value among Medical Diagnostics & Research companies is 0.91, based on 89 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Healius's current Median PS Value of $4.17 is 358.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Healius and its competitors. For the Medical Diagnostics & Research industry, the median Median PS Value is 0.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Healius's current Median PS Value is $4.17, which is 421% above median its own 10-year median of 0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healius stock overvalued right now?
Healius (PHCRF) has a current Median PS Value of $4.17. The stock's GF Value™ is $2.23, compared to a current price of $0.84 — trading 62.3% below its estimated fair value. The current Median PS Value is $4.17, which is 421% above median its 10-year median of 0.80 and 358.2% above the Medical Diagnostics & Research industry median of 0.91. Healius' overall GF Score™ is 47/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Healius (PHCRF), the current Median PS Value is $4.17 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Healius (PHCRF) Overvalued in 2026?
Based on GuruFocus' analysis, Healius stock appears to be undervalued.
The current stock price of $0.84 is trading 62.3% below its estimated GF Value™ of $2.23.
Key valuation signals for PHCRF:
Median PS Value: $4.17 (421% above median its 10-year median of 0.80)
GF Value™: $2.23 vs. price of $0.84 (62.3% below fair value)
Industry Position: 358.2% above the Medical Diagnostics & Research median (#7 of 89)
No single metric tells the full story. See the PHCRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Healius is Australia's second-largest pathology provider. Pathology revenue is almost entirely earned via the public health Medicare system and makes up the majority of Healius' group revenue. A small portion comes from its clinical testing business, Agilex.
47GF Score
Get the complete analysis for PHCRF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHCRF has been successfully added to your 
